Home
Details for: Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial.

Normal view MARC view ISBD view

Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial. [electronic resource]

By:

Hammond, Olivia

Contributor(s):

Reynolds, James
Rubinstein, Leonard J
Sikkema, Daniel
Marchese, Rocio D

Producer: 20090211Description: 332-47 p. digitalISSN:

1532-4230

Subject(s):

Alzheimer Vaccines -- immunology
Amyloid beta-Peptides -- immunology
Animals
Clinical Trials as Topic
Enzyme-Linked Immunosorbent Assay -- standards
Humans
Immunoglobulin G -- blood
Peptide Fragments -- immunology
Research Design -- standards

Online resources:

Available from publisher's website

In: Journal of immunoassay & immunochemistry vol. 29

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 [Injurious effect of lipid peroxidation on human endothelial cells in vitro].
by Chen, T Z
2 [Studies on human endothelial cells in vitro].
by Chen, T Z
3 [Intimal healing process and permeability following mechanical injury to rabbit aorta].
by Chen, T Z
4 [Progress in research on the pathology of atherosclerosis].
by Chen, T Z
5 [Influences of lipid peroxidative injury to endothelial cells on adherence and migration of monocyte].
by Hong, W
6 [Effect of lipid peroxidation injury to endothelial cells (EC) on adherence of monocytes].
by Hong, W
7 [Protective effect of the antioxidants selenium, vitamin E, and superoxide dismutase on cultured human endothelial cells (ECs) injured by lipid peroxidation].
by Yang, X H
8 [Peroxidation injury of endothelial cells and atherosclerosis development].
by Tang, Z H
9 [Method of defining mechanical injury to the intima of the aorta].
by Chen, T Z
10 [Culture of endothelial cells derived from human umbilical cord veins and rat aortas].
by Zhang, B G
11 Specific inhibition of delta antigen by in vitro system by antisense oligodeoxynucleotide: implications for translation mechanism and treatment.
by Chen, T Z
12 A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest.
by Chen, T Z
13 Acute relapsing hepatitis A in Taiwan--a rare event not related to multiple viral infection: a report of two cases.
by Yen, F S
14 Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D.
by Wu, J C
15 Prevalence and type of precore hepatitis B virus mutants in hepatitis D virus superinfection and its clinical implications.
by Wu, J C
16 Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis.
by Yen, F S
17 Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction.
by Wu, J C
18 Further evaluation of one-point microcapsule agglutination test for diagnosis of leptospirosis.
by Cui, J J
19 Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan.
by Chen, T Z
20 Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B.
by Huo, T I

Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial.

APA

Hammond O., Reynolds J., Rubinstein L. J., Sikkema D. & Marchese R. D. (20090211). Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial. : Journal of immunoassay & immunochemistry.

Chicago

Hammond Olivia, Reynolds James, Rubinstein Leonard J, Sikkema Daniel and Marchese Rocio D. 20090211. Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial. : Journal of immunoassay & immunochemistry.

Harvard

Hammond O., Reynolds J., Rubinstein L. J., Sikkema D. and Marchese R. D. (20090211). Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial. : Journal of immunoassay & immunochemistry.

MLA

Hammond Olivia, Reynolds James, Rubinstein Leonard J, Sikkema Daniel and Marchese Rocio D. Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial. : Journal of immunoassay & immunochemistry. 20090211.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC